HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Peritoneovenous shunt in the treatment of therapy resistant ascites. Results of 7 years' experience].

Abstract
In recent years, implantation of a peritoneo-venous shunt has proven effective in the treatment of therapy-resistant ascites. From 1976 till 1983, a total of 63 shunt systems (Le Veen-, Agishi -, Denver system) were implanted in 55 patients with a mean age of 52.3 years. The most common cause for ascites was hepatic cirrhosis. The average functional period amounted to 21.7 months and the longest implantation time to nearly 7 years. The postoperative complication rate is considerable: 19 patients died in the postoperative course. The most dreaded complication is shunt infection and intravascular thrombopathy . In spite of the high complication rate, the establishment of a peritoneo-venous shunt is recommendable for combatting therapy-resistant ascites.
AuthorsH V Zühlke, R Häring, B Semsch
JournalDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen (Chirurg) Vol. 55 Issue 4 Pg. 253-9 (Apr 1984) ISSN: 0009-4722 [Print] Germany
Vernacular TitleDer peritoneo-venöse Shunt zur Behandlung des therapieresistenten Ascites. Ein siebenjähriger Erfahrungsbericht.
PMID6723465 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Ascites (drug therapy)
  • Drug Resistance
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peritoneovenous Shunt (instrumentation, methods)
  • Vascular Surgical Procedures (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: